Human papillomavirus type 16 E2 and E6/E7 variants

被引:31
|
作者
Swan, DC [1 ]
Rajeevan, M
Tortolero-Luna, G
Follen, M
Tucker, RA
Unger, ER
机构
[1] Ctr Dis Control & Prevent, US Dept HHS, Natl Ctr Infect Dis, Publ Hlth Serv, Atlanta, GA 30333 USA
[2] Univ Texas, MD Anderson Canc Ctr, Dept Gynecol Oncol, Houston, TX 77030 USA
关键词
HPV16; variants; E6; E7; E2; cervical disease;
D O I
10.1016/j.ygyno.2004.11.045
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objectives. Polymorphisms in human papillomavirus (HPV) type 16 have been shown to be related to geographic areas and are broadly classified as European (E), African (At), Asian (As), or Asian-American (AA). Certain variants have been reported as being more likely to cause cervical disease; our objectives were to identify new HPV16 polymorphisms, to determine the linkage of the E2 and E6/E7 regions and to determine the minimum sequence necessary to classify variants. Methods. We sequenced the complete E2, E6, and E7 regions in all HPV16-positive cervical samples identified in a case-control study of pre-invasive cervical disease. Results. In the 100 samples analyzed, only one new polymorphism was identified, a synonymous change, T3205A, in region E2. The frequency distribution of variants in the sample set was 37 European prototypes and 27 E-G350, 16 AA, 5 Af1, 2 Af2, 8 E-C109G, 3 E-G131G, and 2 As. As shown by others, region E7 varied much less than E6 and E2. Conclusions. In each case, E2 changes were linked to the expected E6/E7 changes, and there was no evidence for recombination. The linkage between E2 and E6/E7 allows variant classification to be based on a short E6 sequence (nt 109-350). (c) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:695 / 700
页数:6
相关论文
共 50 条
  • [1] Human Papillomavirus 16 E6/E7 Transcript and E2 Gene Status in Patients with Cervical Neoplasia
    Narayanan Sathish
    Priya Abraham
    Abraham Peedicayil
    Gopalan Sridharan
    Subhashini John
    George Chandy
    [J]. Molecular Diagnosis, 2004, 8 (1) : 57 - 64
  • [2] Immortalization of human esophageal keratinocytes by E6 and E7 of human papillomavirus type 16
    Sashiyama, H
    Shino, Y
    Kawamata, Y
    Tomita, Y
    Ogawa, N
    Shimada, H
    Kobayashi, S
    Asano, T
    Ochiai, T
    Shirasawa, H
    [J]. INTERNATIONAL JOURNAL OF ONCOLOGY, 2001, 19 (01) : 97 - 103
  • [3] Human papillomavirus: E6 and E7 oncogenes
    Boulet, Gaele
    Horvath, Caroline
    Broeck, Davy Vanden
    Sahebali, Shaira
    Bogers, Johannes
    [J]. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2007, 39 (11): : 2006 - 2011
  • [4] Evidence of diversifying selection in human papillomavirus type 16 E6 but not E7 oncogenes
    DeFilippis, VR
    Ayala, FJ
    Villarreal, LP
    [J]. JOURNAL OF MOLECULAR EVOLUTION, 2002, 55 (04) : 491 - 499
  • [5] DNA vaccines against the human papillomavirus type 16 E6 or E7 oncoproteins
    Wlazlo, AP
    Deng, HY
    Giles-Davis, W
    Ertl, HCJ
    [J]. CANCER GENE THERAPY, 2004, 11 (06) : 457 - 464
  • [6] Evidence of Diversifying Selection in Human Papillomavirus Type 16 E6 But Not E7 Oncogenes
    Victor R. DeFilippis
    Francisco J. Ayala
    Luis P. Villarreal
    [J]. Journal of Molecular Evolution, 2002, 55 : 491 - 499
  • [7] DNA vaccines against the human papillomavirus type 16 E6 or E7 oncoproteins
    Anthony P Wlazlo
    Hongying Deng
    Wynetta Giles-Davis
    Hildegund C J Ertl
    [J]. Cancer Gene Therapy, 2004, 11 : 457 - 464
  • [8] Antibodies against human papillomavirus (HPV) type 16 and 18 E2, E6 and E7 proteins in sera:: Correlation with presence of papillomavirus DNA
    Rosales, R
    López-Contreras, M
    Cortes, RR
    [J]. JOURNAL OF MEDICAL VIROLOGY, 2001, 65 (04) : 736 - 744
  • [10] Extended lifespan and immortalization of normal human fibroblasts by introduction of human papillomavirus (HPV) type 16 E6, E7 or E6/E7 gene.
    Yamamoto, A
    Kumakura, S
    Uchida, M
    Annab, L
    Barrett, JC
    Tsutsui, T
    [J]. MOLECULAR BIOLOGY OF THE CELL, 1997, 8 : 872 - 872